Literature DB >> 6927210

Variation in postoperative analgesic requirements in the morbidly obese following gastric bypass surgery.

R Bennett, R Batenhorst, D A Graves, T S Foster, W O Griffen, B D Wright.   

Abstract

Patient-controlled analgesia is a relatively new method of administering intravenous narcotics for postoperative pain relief. The technique involves the self-administration of a given analgesic in a bolus dose with the aid of a timed infusion and sequencing device. Ten morbidity obese patients undergoing elective gastric bypass surgery were treated in a prospective, unblinded, pilot project to evaluate the efficacy of patient-controlled analgesia. Analgesic therapy was satisfactory in all patients. The mean total dose of morphine sulfate administered during the first 36 hours postoperatively was 66 mg, an average of 1.7 mg/hr. There was a tenfold variation (17.5-175 mg) in the 36 hr total dose. The total dose was not related to body surface area, age, sex, dose per injection, or anesthetic agent. The large variation in individual narcotic analgesic requirements could be a major factor in the suboptimal management of postoperative pain with conventional dosing. Patient-controlled analgesia may circumvent these problems.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6927210     DOI: 10.1002/j.1875-9114.1982.tb03172.x

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  7 in total

1.  Modifiers of Patient-Controlled Analgesia Efficacy in Acute and Chronic Pain.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 2.  Management of post-operative pain.

Authors:  G Smith
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

3.  Anaesthetic management of a super morbidly obese patient for total abdominal hysterectomy: a few more lessons to learn.

Authors:  S Fyneface-Ogan; D S Abam; C Numbere
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 4.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 5.  Dosing of medications in morbidly obese patients in the intensive care unit setting.

Authors:  Brian L Erstad
Journal:  Intensive Care Med       Date:  2003-11-19       Impact factor: 17.440

Review 6.  Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors.

Authors:  Cynthia Wei-Sheng Lee; Ing-Kang Ho
Journal:  Mol Pain       Date:  2013-09-08       Impact factor: 3.395

Review 7.  Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium.

Authors:  Brian L Erstad; Jeffrey F Barletta
Journal:  Crit Care       Date:  2020-06-08       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.